Compounders Research Compare

PMGC Holdings Inc.(ELAB)

Biotechnology · Newport Beach, CA

$3.26-0.01 (-0.31%)

Delayed quote: Oct 6, 2026, 3:40 PM EDT

About PMGC Holdings Inc.

PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering engineered probiotic designed to tackle the critical challenge of maintaining muscle mass during weight reduction regimens, especially those utilizing GLP-1 receptor agonists. Beyond its core operations, the company also engages in medical scientific research and development and manages various investment firms. Formerly known as Elevai Labs, Inc., the organization adopted its current name, PMGC Holdings Inc., in December 2024. Established in 2020, PMGC Holdings Inc. maintains its headquarters in Newport Beach, California.

Newport Beach, CA

33 employees

pmgcholdings.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Graydon Bensler

View full financials

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T19:41:23.614Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:41:23.614Z.

Quote observation: 2026-10-06T19:40:16.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 1,481,263
Total debt · period ending 2026-06-30: 13,916,785
Cash · period ending 2026-06-30: 18,141,758
TTM operating EBITDA · period ending 2026-06-30: -11,740,887

FMP input reference: ec04a23f2eccb1c46d806cafb3c6508f31619b4012dc27c85b71ebd533873098

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

ELAB EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

ELAB Competitors' EV/EBITDA Ratio

PMGC Holdings Inc.

Current

Market Cap

$1.48M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Curis, Inc.

Market Cap

$1.48M

EV/EBITDA Ratio

N/A

TTM Avg

341.73x

3Y Avg

341.73x

5Y Avg

341.73x

Lakewood-Amedex Biotherapeutics, Inc.

Market Cap

$1.51M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NEXGEL, Inc.

Market Cap

$1.45M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INVO Fertility, Inc.

Market Cap

$1.42M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Jupiter Neurosciences, Inc.

Market Cap

$1.34M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NewcelX Ltd.

Market Cap

$1.33M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Genprex, Inc.

Market Cap

$1.33M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Artelo Biosciences, Inc.

Market Cap

$1.32M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Silo Pharma, Inc.

Market Cap

$1.65M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
PMGC Holdings Inc. (ELAB)	$1.48M	N/A	N/A	N/A	N/A
Curis, Inc. (CRIS)vs ›	$1.48M	N/A	341.73x	341.73x	341.73x
Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs ›	$1.51M	N/A	N/A	N/A	N/A
NEXGEL, Inc. (NXGL)vs ›	$1.45M	N/A	N/A	N/A	N/A
INVO Fertility, Inc. (IVF)vs ›	$1.42M	N/A	N/A	N/A	N/A
Jupiter Neurosciences, Inc. (JUNS)vs ›	$1.34M	N/A	N/A	N/A	N/A
NewcelX Ltd. (NCEL)vs ›	$1.33M	N/A	N/A	N/A	N/A
Genprex, Inc. (GNPX)vs ›	$1.33M	N/A	N/A	N/A	N/A
Artelo Biosciences, Inc. (ARTL)vs ›	$1.32M	N/A	N/A	N/A	N/A
Silo Pharma, Inc. (SILO)vs ›	$1.65M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics